Ornithine transcarbamylase (OCT) deficiency is an X-linked inborn erro
r of metabolisme and the most common inherited urea cycle defect. Homo
zygous males develop hyperammonienic encephalopathy and usually die in
the neonatal period. Delayed manifestations have been reported in a f
ew male and female patients with heterozygous OCT deficiency. Most of
these manifestations have been intermittent and non specific, such as
loss of appetite, an aversion to high protein foods, headache, vomitin
g, behavioral disorders, irritability, and transient motor deficits. T
he diagnosis rests on demonstration of hyperammonemia, increased urina
ry excretion of erotic acid, and decreased OCT activity in a biopsy of
the liver or jejunum.